ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,838Medicare Part D Prescriptions Filled, Including Refills

Rank: 381 out of 1107

$488K Total Retail Price of All Prescriptions

Rank: 392 out of 1107

314 Patients Receiving at Least One Drug in Part D
32%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 314 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 314 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

0% of this provider’s 3,300 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 440 164 1 2
OMEPRAZOLE 423 178 2 4
GABAPENTIN 279 64 3 9
AMLODIPINE BESYLATE 277 149 4 6
SIMVASTATIN 275 141 5 5
LEVOTHYROXINE SODIUM 264 112 6 3
METFORMIN HCL 255 106 7 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 242 86 8 24
CITALOPRAM HBR 184 30 9 17
HYDROCODONE-ACETAMINOPHEN 159 52 S3 10 1
PRAVASTATIN SODIUM 148 65 11 12
TRAZODONE HCL 142 69 12 33
ATENOLOL 136 64 13 19
FUROSEMIDE 136 59 13 7
METOPROLOL TARTRATE 133 40 15 10
MELOXICAM 116 35 16 25
PROAIR HFA 111 39 17 37
HYDROCHLOROTHIAZIDE 102 31 18 11
CLOPIDOGREL 94 54 19 28
NEXIUM 87 28 20 18
LYRICA 86 0 21 83
FLUTICASONE PROPIONATE 80 30 22 38
CARVEDILOL 80 45 22 27
ADVAIR DISKUS 79 0 24 54
ATORVASTATIN CALCIUM 77 31 25 13
LOSARTAN POTASSIUM 76 51 26 29
CRESTOR 75 26 27 23
RANITIDINE HCL 72 36 28 21
POTASSIUM CHLORIDE 71 35 29 14
CYCLOBENZAPRINE HCL 70 0 R 30 56
COMBIVENT 67 17 31 112
PLAVIX 65 36 32 39
PREDNISONE 65 11 32 40
SPIRIVA 63 31 34 57
SERTRALINE HCL 63 35 34 20
OXYBUTYNIN CHLORIDE 60 47 36 171
GLIPIZIDE 58 28 37 64
PANTOPRAZOLE SODIUM 54 12 38 30
CYMBALTA 54 14 38 50
VENTOLIN HFA 54 16 38 97
LANTUS 53 0 41 49
SINGULAIR 53 0 41 65
BACLOFEN 51 0 43 133
OXYCODONE-ACETAMINOPHEN 51 23 S2 43 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.